can you take semaglutide with type 1 diabetes Effectiveness and Safety of in Diabetes: A Danish Nationwide Cohort Study (2018–2024) After treatment with semaglutide, newly

incretin and energy-expenditure signaling Mechanism Single-molecule triple incretin / glucagon receptor agonist Research area Metabolic, body-weight and glycemic research Physical properties Handling & Storage Appearance White lyophilized powder Solubility Soluble in sterile water

Both remain investigational, with no direct head-to-head comparison

Symptomatic hypoglycemia remained uncommon (3.77.5%), with a similar proportion of patients with events in the placebo arm (7.5%)

Consistent with the prescribing information for these medications, health care professionals should monitor for and advise patients using GLP-1 RAs to report new or worsening depression, suicidal thoughts, or any unusual changes in mood or behavior